Furthermore, we explored the correlation of TGFBI/TAGLN expression with stem cell markers (NANOG, POU5F1, SOX2, ALDH1, and BCL11B) and EMT markers (S100A4 and VIM) in HNSCC cells. This evidence concerns the gene BCL11B and head and neck squamous cell carcinoma.